Aster Healthcare (Large Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Aster DM Healthcare Limited |
|||
|
Price: ₹486.35 | ||
| 52 Week Low: ₹311.10 52 Week High: ₹558.00 |
|||
| Market Capital: 21,566.79 Crore (Largecap) | |||
| Healthcare -> Medical Care Facilities | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Aster Healthcare Share Price Target For 2024
- 1.1.1: Aster Healthcare Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Aster Healthcare Share Price Target For 2025
- 1.2.1: Aster Healthcare Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Aster Healthcare Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Aster Healthcare Brief Company Overview
- 4: Aster Healthcare Financial Performance
- 4.0.1: Is Aster Healthcare A Good Buy For Long Term?
To predict the Aster Healthcare's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Aster Healthcare Share Price Target For 2024
The line chart displays the monthly closing prices of Aster Healthcare with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Aster Healthcare shares in 2024, see the table below.
Aster Healthcare Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 507.5 (+4.34%) | Price Action: 20 Dec 2024 High |
| 2024 Target 2 | 498.6 (+2.51%) | Price Action: 03 Dec 2024 High |
| 2024 Target 1 | 493.6 (+1.49%) | Price Action: 10 Dec 2024 High |
| Current Price | 486.35 | Aster Healthcare's share price as of 20 Dec 2024 |
| Stop Loss 1 | 481.55 (-0.99%) | Price Action: 03 Dec 2024 Low |
| Stop Loss 2 | 475.54 (-2.23%) | Price Action: 28 Nov 2024 Low |
| Stop Loss 3 | 464.0 (-4.60%) | Price Action: Oct 2024 High |
Short-Term Technical Outlook
Current Technical Position: Aster Healthcare is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹472.63 serves as the nearest technical reference point.
Historical Returns: 3-month: +17.16% | 6-month: +41.00% | 1-year: +54.88%
Aster Healthcare Share Price Target For 2025
The line chart displays the monthly closing prices of Aster Healthcare with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Aster Healthcare shares in 2025, see the table below.
Aster Healthcare Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 672.96 (+38.36%) | Price Action: Chart |
| 2025 Target 2 | 660.41 (+35.78%) | Price Action: Chart |
| 2025 Target 1 | 653.87 (+34.44%) | Fibonacci Extension Level 64.90% |
| Current Price | 486.35 | Aster Healthcare's share price as of 20 Dec 2024 |
| Stop Loss 1 | 446.0 (-8.30%) | Price Action: 31 Oct 2024 High |
| Stop Loss 2 | 441.35 (-9.26%) | Price Action: 01 Nov 2024 Low |
| Stop Loss 3 | 436.5 (-10.25%) | Price Action: 18 Nov 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: Aster Healthcare is currently trading at 71.0% of its 52-week range (₹311.1 - ₹558).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +54.88% | 3-year: +265.18% | 5-year: +294.83%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Aster Healthcare Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹486.35 | ||
| 2024 | ₹437.01 | -10.14% | ₹443.57 |
| 2025 | ₹509.38 | +16.56% | ₹517.02 |
| 2026 | ₹548.23 | +7.63% | ₹556.45 |
| 2027 | ₹601.88 | +9.79% | ₹621.86 |
| 2028 | ₹690.03 | +14.65% | ₹700.38 |
| 2029 | ₹768.14 | +11.32% | ₹779.66 |
| 2030 | ₹844.54 | +9.95% | ₹857.21 |
| 2031 | ₹867.00 | +2.66% | ₹880.00 |
| 2032 | ₹915.40 | +5.58% | ₹951.51 |
| 2033 | ₹1,015.55 | +10.94% | ₹1,030.78 |
| 2034 | ₹1,099.26 | +8.24% | ₹1,115.75 |
| 2035 | ₹1,179.71 | +7.32% | ₹1,197.41 |
| 2036 | ₹1,185.78 | +0.51% | ₹1,203.57 |
| 2037 | ₹1,228.91 | +3.64% | ₹1,281.25 |
| 2038 | ₹1,341.07 | +9.13% | ₹1,364.74 |
| 2039 | ₹1,371.47 | +2.27% | ₹1,431.08 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Aster Healthcare Brief Company Overview
Company Overview Aster DM Healthcare Limited, established in 1987, is a leading healthcare provider operating across 8 countries in the Middle East, India, and Mauritius. The company has a strong presence in the region with a diverse product range. Key Products and...
Services Hospitals and in-house pharmacies Clinics and in-house pharmacies Retail pharmacies and optical outlets Healthcare consultancy Other healthcare services Industry Reputation Aster DM Healthcare is committed to providing quality healthcare, making it a well-respected player in the industry. Market Presence The company operates in India, UAE, Qatar, Oman, Saudi Arabia, Jordan, Kuwait, Bahrain, and Mauritius. Commitment Aster DM Healthcare is committed to providing accessible, affordable, and compassionate healthcare to communities it serves.Aster Healthcare Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 21,566.79 Crore | Market valuation of Aster Healthcare's shares. |
| Revenue (TTM) | 4,016.56 Crore | Total revenue generated by Aster Healthcare over the past twelve months. |
| Net Income (TTM) | +2,260,499,968.00 | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +14.49% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +134.37% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-67.20% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
53.87 | Company's total debt divided by total shareholder equity. |
| Total Debt | 1,940.27 Crore | Sum of Aster Healthcare's current & long-term financial obligations. |
| Total Cash | 1,578.16 Crore | Total amount of liquid funds available to Aster Healthcare. |
| Beta | 0.61 | Beta is less than 1 indicating that the Aster Healthcare's price is less volatile than the market. |
Is Aster Healthcare A Good Buy For Long Term?
Aster Healthcare, a large-cap stock with a market capitalization of ₹21,566.79 crore, shows strong past performance (3-year return: 160.65%, 5-year return: 178.35%). However, Q2 2024-25 reveals a significant -67.2% revenue drop quarter-over-quarter, despite a high profit margin of 134.37%. While it boasts ₹1,578.16 crore in cash and a substantial net profit of ₹226.04 crore (TTM), a debt of ₹1,940.27 crore raises concerns. Given the recent revenue decline and high debt, it's currently an average buy for long-term investment, warranting further analysis of the revenue drop's cause.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
